Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Заболявания:
Metastatic Breast Cancer
Спонсор: Eli Lilly and Company
Налично на:
БГ
Обобщение
The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.
Кой може да участва
Inclusion Criteria:
* Patients with hormone receptor positive metastatic breast cancer for whom there is reasonable expectation that abemaciclib may provide clinical benefit and who are suitable to receive abemaciclib.
Места на провеждане
14
Австралия (1)
Liverpool Hospital
Liverpool , New South Wales
Канада (1)
Tom Baker Cancer Center
Calgary , Alberta
Egypt (1)
Cairo Oncology Center (Cairo Cure)
Mohandeseen , Cairo Governorate
Индия (1)
Apollo Cancer Institute, Apollo Speciality Hospital
Teynampet , Chennai
Италия (1)
Azienda Ospedaliera Universitaria Policlinico Tor Vergata
БГ
EN